UK MHRA Presses For Leading Global Role Post-Brexit
Executive Summary
The UK MHRA believes it has a valid and vital role to play on the global regulatory stage even after the UK leaves the EU.
You may also be interested in...
Brexit, Brexit Everywhere And Such A Lot To Think
For medtech manufacturers working in the EU market, the biggest regulatory changes for a generation are on the cusp of coming into force – at last. Or does this spell double trouble for UK manufacturers, who are rightly nervous about how Brexit will alter their business?
DTx And Drug Deal Sees Closed Loop Medicine And Teva Team Up On Precision Care
Medicines are still typically prescribed based on average effects in a population and rarely dose-optimized for the individual, says Closed Loop Medicine. The company sees a new strategic partnership with Teva UK as another step in advancing personalized medicine.
Swiss-EU Standoff Set To End? Medtechs Eye MRA Action
Negotiations aimed at renewing the close trading relationship and barrier-free mutual market access between Switzerland and the EU got underway on 19 March. Swiss medtech companies welcomed the move, stressing the need for the defunct mutual recognition agreement to be updated.